Study population [Design Issues]

posted by avrahan – 2014-10-20 17:17 (4268 d 09:56 ago) – Posting: # 13758
Views: 4,377

Dear All

I would like to perform a BE study for a drug indicated to:
  1. Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets.
  2. Also indicated for use in secondary amenorrhea.
In this case should I recruit females with postmenopausal condition or no restriction should be done? :confused:

Thanks for your reply.

Regards

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
370 visitors (0 registered, 370 guests [including 19 identified bots]).
Forum time: 03:14 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5